Triterpenoids from Ocimum labiatum Activates Latent HIV-1 Expression In Vitro: Potential for Use in Adjuvant Therapy. (Q43924337)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

title

Triterpenoids from Ocimum labiatum Activates Latent HIV-1 Expression In Vitro: Potential for Use in Adjuvant Therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ocimum labiatum

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Petrina Kapewangolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Justin J Omolo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Martha Kandawa-Schulz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Debra Meyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

language of work or name

English

0 references

publication date

13 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

7 April 2020

copyright license

start time

13 October 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

HIV-1 latent reservoir: size matters

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Latency: the hidden HIV-1 challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

HIV reservoirs and the possibility of a cure for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Eradicating HIV-1 infection: seeking to clear a persistent pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

HIV Latency: Should We Shock or Lock?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Computer-guided design, synthesis, and protein kinase C affinity of a new salicylate-based class of bryostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Natural Products as Sources of New Drugs from 1981 to 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Bioactive diterpenes from Orthosiphon labiatus and Salvia africana-lutea

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp. intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-o-(3',3'-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Progress and challenges in the use of latent HIV-1 reactivating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Beta-amyrin synthase--cloning of oxidosqualene cyclase that catalyzes the formation of the most popular triterpene among higher plants

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Can research at the end of life be a useful tool to advance HIV cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Protective effect of alpha- and beta-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Therapy for latent HIV-1 infection: the role of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

In vitro reactivation of latent HIV-1 by cytostatic bis(thiosemicarbazonate) gold(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

The Th1/Th2/Th17 cytokine profile of HIV-infected individuals: a multivariate cytokinomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Biomarkers of immune dysfunction in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Time dependent production of cytokines and eicosanoids by human monocytic leukaemia U937 cells; effects of glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Separation and identification of some common isomeric plant triterpenoids by thin-layer chromatography and high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Antioxidant and anti-inflammatory activity of Ocimum labiatum extract and isolated labdane diterpenoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Targeting HIV latency: pharmacologic strategies toward eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

A fluorogenic histone deacetylase assay well suited for high-throughput activity screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Isolation and structure of bryostatin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22101703

Bioactive apocarotenoids from Tectona grandis

21 January 2018

1 reference

12 December 2020

Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.

1 reference

12 December 2020

Kleinhospitines A-D, new cycloartane triterpenoid alkaloids from Kleinhovia hospita

1 reference

12 December 2020

Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes

1 reference

12 December 2020

10.3390/MOLECULES22101703

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29027985%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference